0 followers
TenSixteen Bio is the first company to leverage somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics to treat age-related diseases.
Elicio Therapeutics
1 follower
Halda Therapeutics
1 follower
Thermo Fisher Scientific
157 followers
GRAIL
27 followers
Cytokinetics
11 followers
SpringWorks Therapeutics
5 followers
Artivion
3 followers
Axsome Therapeutics
2 followers
BridgeBio
2 followers
Immunome
2 followers
Hawaii Fire Department
4 followers
Explore companies